Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia.

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82.

View in: PubMed

subject areas

Adolescent
Adult
Apoptosis
Blotting, Western
Cell Cycle
Cell Line, Tumor
Enzyme Inhibitors
Female
Flow Cytometry
Fluorescent Antibody Technique
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute
Male
Middle Aged
Oligonucleotide Array Sequence Analysis
Real-Time Polymerase Chain Reaction
Transfection
Young Adult

authors with profiles

Yusuke Nakamura
Wendy Stock